Literature DB >> 23604593

ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review.

Petar Lenert1, Michael Icardi, Laila Dahmoush.   

Abstract

Minocycline is a synthetic tetracycline-derived antibiotic with significant anti-inflammatory properties that may benefit patients with rheumatoid arthritis. Surprisingly, chronic exposure to minocycline can also cause a breach in immunologic tolerance resulting in a variety of autoimmune syndromes such as drug-induced lupus or autoimmune hepatitis. Vasculitis, most commonly resembling cutaneous polyarteritis nodosa, has also been seen in patients taking this drug. Herein, we present a case of biopsy-proven systemic vasculitis presenting as an ANA (+) ANCA (+) polyarteritis nodosa-like syndrome in a male patient who was taking minocycline for his acne for approximately 2 years. Patient initially presented with constitutional symptoms such as profound weight loss and fatigue, along with myalgias, oligoarticular arthritis, and livedo reticularis. About 2 months later, he developed a severe left testicular pain. Biopsy showed vasculitis complicated with the infarction of the left testis. Angiography revealed microaneurysms in the renal and splenic circulation. Stopping the offending drug, along with the short course of prednisone and hydroxychloroquine, resulted in prompt resolution of his symptoms. We additionally present a comprehensive review of biopsy-proven cases of vasculitis associated with chronic minocycline treatment focusing on its pathogenesis and clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23604593     DOI: 10.1007/s10067-013-2245-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  39 in total

1.  Additional case of minocycline-induced cutaneous polyarteritis nodosa: comment on the article by Culver et al.

Authors:  Sébastien Abad; Marianne Kambouchner; Mohamed Nejjari; Robin Dhote
Journal:  Arthritis Rheum       Date:  2006-10-15

2.  Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris.

Authors:  B J Schrodt; J P Callen
Journal:  Pediatrics       Date:  1999-02       Impact factor: 7.124

Review 3.  Drugs associated with vasculitis.

Authors:  P A Merkel
Journal:  Curr Opin Rheumatol       Date:  1998-01       Impact factor: 5.006

4.  Lupus-like syndrome in patients treated for acne.

Authors:  N S Gendi; S J Bowman; A G Mowat
Journal:  Br J Rheumatol       Date:  1995-06

5.  Minocycline-related lupus.

Authors:  D Y Bulgen
Journal:  Br J Rheumatol       Date:  1995-04

6.  Minocycline and lupuslike syndrome in acne patients.

Authors:  M C Sturkenboom; C R Meier; H Jick; B H Stricker
Journal:  Arch Intern Med       Date:  1999-03-08

7.  Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris.

Authors:  J V Schaffer; D M Davidson; J M McNiff; J L Bolognia
Journal:  J Am Acad Dermatol       Date:  2001-02       Impact factor: 11.527

8.  Minocycline-induced lupus: clinical features and response to rechallenge.

Authors:  T M Lawson; N Amos; D Bulgen; B D Williams
Journal:  Rheumatology (Oxford)       Date:  2001-03       Impact factor: 7.580

Review 9.  [Two cases of minocycline-induced vasculitis].

Authors:  Hiroyuki Sakai; Shigetsuna Komatsu; Shinobu Matsuo; Hajime Iizuka
Journal:  Arerugi       Date:  2002-12

Review 10.  Drug-induced autoimmune-like hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-02-16       Impact factor: 3.487

View more
  15 in total

Review 1.  Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis.

Authors:  Fernando Bessone; Natalia Poles; Marcelo G Roma
Journal:  World J Hepatol       Date:  2014-06-27

Review 2.  Drug-induced glomerular disease: immune-mediated injury.

Authors:  Jonathan J Hogan; Glen S Markowitz; Jai Radhakrishnan
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-19       Impact factor: 8.237

Review 3.  Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.

Authors:  Francois Chasset; Camille Francès
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

4.  Minocycline-associated vasculitis of extracranial branches of vertebral arteries presenting as myelopathy.

Authors:  Neha Garg; Gadah H Altowaijri; Gary M Nesbit; Sakir Humayun Gultekin; Dennis N Bourdette
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-05-15

Review 5.  Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.

Authors:  Aleksander Lenert; Petar Lenert
Journal:  Drug Des Devel Ther       Date:  2015-01-07       Impact factor: 4.162

6.  Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial.

Authors:  Anuja P Shah; Jenny I Shen; Ying Wang; Lili Tong; Youngju Pak; Ali Andalibi; Janine A LaPage; Sharon G Adler
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

7.  Testicular Pain Associated With Minocycline Use.

Authors:  Victor Kucherov; William Hulbert; Guan Wu
Journal:  Urol Case Rep       Date:  2015-03-02

8.  In Vitro Effects of Some Botanicals with Anti-Inflammatory and Antitoxic Activity.

Authors:  Gianandrea Guidetti; Alessandro Di Cerbo; Angela Giovazzino; Valentina Rubino; Anna Teresa Palatucci; Sara Centenaro; Elena Fraccaroli; Laura Cortese; Maria Grazia Bonomo; Giuseppina Ruggiero; Sergio Canello; Giuseppe Terrazzano
Journal:  J Immunol Res       Date:  2016-08-15       Impact factor: 4.818

Review 9.  Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.686

10.  Toxicological Implications and Inflammatory Response in Human Lymphocytes Challenged with Oxytetracycline.

Authors:  A Di Cerbo; A T Palatucci; V Rubino; S Centenaro; A Giovazzino; E Fraccaroli; L Cortese; G Ruggiero; G Guidetti; S Canello; G Terrazzano
Journal:  J Biochem Mol Toxicol       Date:  2015-11-05       Impact factor: 3.642

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.